Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Sara Dong

Transplant/Immunocompromised States · Boston Children's Hospital

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Keith Kaye

General ID · RU

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Kelly Dooley

Mycobacterial Disease · Vanderbilt

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Intraabdominal Infections.

    Aug 6, 2025DOI: 10.1093/cid/ciaf299Journal ArticleCID

    Written by: Abigail RaderFelicia RuffinCaitlin FaiKaren D BartonLesley A SkallaTsai-Wei WangMegan OakesKatherine N SuttonJulie MillerDeborah CollyarHelen W BoucherSarah B DoernbergBryce B ReeveHeather A King

    Find these authors on Roon

    HB
    Dr. Helen Boucher
    Transplant/Immunocompromised States · Tufts

    Summary

    BACKGROUND: In this systematic review, we assessed health-related quality-of-life (HRQoL) measures in patients with complicated intraabdominal infections (cIAIs) commonly associated with sepsis and evaluated the impact of cIAIs on HRQoL.METHODS: Following a prospectively registered protocol in PROSPERO (CRD42021255827), we searched electronic databases, including MEDLINE (PubMed), EMBASE (Elsevier), and CINAHL (EBSCO), from database inception through September 2022 to identify studies that measured HRQoL in patients with cIAIs.RESULTS: We identified 93 articles that included 45 HRQoL measures: 32 generic, 5 condition-specific, and 8 symptom-specific. Additionally, in 12 studies, researchers developed their own HRQoL questions or questionnaires. The measures evaluated symptom status (30 measures), functioning (39 measures), general health perceptions (8 measures), and overall HRQoL (12 measures). Article results showed that HRQoL in patients with cIAIs improved over time post-treatment and that symptoms, including pain, fatigue, and incontinence, were common. Only the diverticulitis quality-of-life (DV-QoL) instrument had been psychometrically tested in patients with cIAI.CONCLUSIONS: This review highlights the need for disease-specific HRQoL measures that are rigorously tested and validated in patient populations with cIAIs, which can be informed by the DV-QoL.
    HBDr. Helen Boucher
    Leading Voice

    Dr. Helen Boucher

    Infectious Disease · Transplant/Immunocompromised States
    Tufts University
    helen